![Cancers | Free Full-Text | Long Non-Coding RNAs in Pancreatic Cancer: Biologic Functions, Mechanisms, and Clinical Significance | HTML Cancers | Free Full-Text | Long Non-Coding RNAs in Pancreatic Cancer: Biologic Functions, Mechanisms, and Clinical Significance | HTML](https://www.mdpi.com/cancers/cancers-14-02115/article_deploy/html/images/cancers-14-02115-g001.png)
Cancers | Free Full-Text | Long Non-Coding RNAs in Pancreatic Cancer: Biologic Functions, Mechanisms, and Clinical Significance | HTML
![First-line immune-checkpoint inhibitor combination therapy for chemotherapy-eligible patients with metastatic urothelial carcinoma: A systematic review and meta-analysis - European Journal of Cancer First-line immune-checkpoint inhibitor combination therapy for chemotherapy-eligible patients with metastatic urothelial carcinoma: A systematic review and meta-analysis - European Journal of Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a82aa05d-9fcc-4653-a215-ee5bf567ea54/gr1a_lrg.jpg)
First-line immune-checkpoint inhibitor combination therapy for chemotherapy-eligible patients with metastatic urothelial carcinoma: A systematic review and meta-analysis - European Journal of Cancer
Discovery of Entrectinib: A New 3-Aminoindazole As a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor | Journal of Medicinal Chemistry
![New developments in the biology of fibroblast growth factors - Ornitz - 2022 - WIREs Mechanisms of Disease - Wiley Online Library New developments in the biology of fibroblast growth factors - Ornitz - 2022 - WIREs Mechanisms of Disease - Wiley Online Library](https://wires.onlinelibrary.wiley.com/cms/asset/616ca467-bd3d-4bf6-b4dc-8164166384fe/wsbm1549-toc-0001-m.jpg)
New developments in the biology of fibroblast growth factors - Ornitz - 2022 - WIREs Mechanisms of Disease - Wiley Online Library
![Cancers | Free Full-Text | Immune Response in Vitamin D Deficient Metastatic Colorectal Cancer Patients: A Player That Should Be Considered for Targeted Vitamin D Supplementation Cancers | Free Full-Text | Immune Response in Vitamin D Deficient Metastatic Colorectal Cancer Patients: A Player That Should Be Considered for Targeted Vitamin D Supplementation](https://www.mdpi.com/cancers/cancers-14-02594/article_deploy/html/images/cancers-14-02594-g001.png)
Cancers | Free Full-Text | Immune Response in Vitamin D Deficient Metastatic Colorectal Cancer Patients: A Player That Should Be Considered for Targeted Vitamin D Supplementation
![Current Oncology | Free Full-Text | Circulating Tumor DNA in Gastric and Gastroesophageal Junction Cancer | HTML Current Oncology | Free Full-Text | Circulating Tumor DNA in Gastric and Gastroesophageal Junction Cancer | HTML](https://www.mdpi.com/curroncol/curroncol-29-00120/article_deploy/html/images/curroncol-29-00120-g001.png)
Current Oncology | Free Full-Text | Circulating Tumor DNA in Gastric and Gastroesophageal Junction Cancer | HTML
![Cancers | Free Full-Text | FGFR Inhibitors in Oncology: Insight on the Management of Toxicities in Clinical Practice | HTML Cancers | Free Full-Text | FGFR Inhibitors in Oncology: Insight on the Management of Toxicities in Clinical Practice | HTML](https://www.mdpi.com/cancers/cancers-13-02968/article_deploy/html/images/cancers-13-02968-g001.png)
Cancers | Free Full-Text | FGFR Inhibitors in Oncology: Insight on the Management of Toxicities in Clinical Practice | HTML
Molecular Assemblies Offering Hydrogen-Bonding Cavities: Influence of Macrocyclic Cavity and Hydrogen Bonding on Dye Adsorption | Inorganic Chemistry
Stable Metal–Organic Frameworks with Group 4 Metals: Current Status and Trends | ACS Central Science
Pooled Safety and Efficacy Analysis Examining the Effect of Performance Status on Outcomes in Nine First-Line Treatment Trials U
![The use of high-throughput screening in identifying chemotherapeutic agents for gastric cancer | Future Medicinal Chemistry The use of high-throughput screening in identifying chemotherapeutic agents for gastric cancer | Future Medicinal Chemistry](https://www.future-science.com/cms/10.4155/fmc.14.131/asset/images/medium/figure2.gif)
The use of high-throughput screening in identifying chemotherapeutic agents for gastric cancer | Future Medicinal Chemistry
![Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing | British Journal of Cancer Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-022-01908-1/MediaObjects/41416_2022_1908_Fig1_HTML.png)
Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing | British Journal of Cancer
ESPNcricinfo - Four overs 24 runs Two wickets 11 dots Just Jasprit Bumrah things 🔥 #IPL2021 ⏩ es.pn/IPL2021-M42 | Facebook
![Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis - European Journal of Cancer Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis - European Journal of Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/6fa01285-0d7b-40e9-a367-e34959259d2b/gr1_lrg.jpg)
Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis - European Journal of Cancer
![Comparison of Tissue Abundance of Non-Cytochrome P450 Drug-Metabolizing Enzymes by Quantitative Proteomics between Humans and Laboratory Animal Species | Drug Metabolism & Disposition Comparison of Tissue Abundance of Non-Cytochrome P450 Drug-Metabolizing Enzymes by Quantitative Proteomics between Humans and Laboratory Animal Species | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/sites/default/files/highwire/dmd/50/3.cover-source.jpg)
Comparison of Tissue Abundance of Non-Cytochrome P450 Drug-Metabolizing Enzymes by Quantitative Proteomics between Humans and Laboratory Animal Species | Drug Metabolism & Disposition
![Sustained Tumor Regression With Zenocutuzumab, a Bispecific Antibody Targeting Human Epidermal Growth Factor Receptor 2/Human Epidermal Growth Factor Receptor 3 Signaling, in NRG1 Fusion–Positive, Estrogen Receptor–Positive Breast Cancer After ... Sustained Tumor Regression With Zenocutuzumab, a Bispecific Antibody Targeting Human Epidermal Growth Factor Receptor 2/Human Epidermal Growth Factor Receptor 3 Signaling, in NRG1 Fusion–Positive, Estrogen Receptor–Positive Breast Cancer After ...](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/po/2022/po.2022.6/po.21.00446/20220812/images/keyimage.jpg)